Evidence map›Paper›PMID 31519925›Full record

ArticleScientific reports2019

A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients.

Javier Rodríguez-Carrio, Natalia Carrillo-López, Catalina Ulloa, Mariana Seijo, Minerva Rodríguez-García, Carmen Rodríguez-Suárez, Carmen Díaz-Corte, Jorge B Cannata-Andía, Ana Suárez, Adriana S Dusso

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Target neutrophil heterogeneity and plasticity in cancer.Journal of hematology & oncology · 2025
    Review
  5. Neutrophils and NETs in kidney disease.Nature reviews. Nephrology · 2025
    Review
  6. Review
  7. Neutrophils-biology and diversity.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Javier Rodríguez-CarrioArea of Immunology, Department of Functional Biology, University of Oviedo, Oviedo, Spain.
Natalia Carrillo-LópezBone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Catalina UlloaDivision of Nephrology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Mariana SeijoBone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Minerva Rodríguez-GarcíaRed de Investigación Renal (REDinREN), Instituto de Salud Carlos III (ISCIII), Hospital Universitario Central de Asturias, Oviedo, Spain.
Carmen Rodríguez-SuárezDivision of Nephrology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Carmen Díaz-CorteRed de Investigación Renal (REDinREN), Instituto de Salud Carlos III (ISCIII), Hospital Universitario Central de Asturias, Oviedo, Spain.
Jorge B Cannata-AndíaBone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Ana SuárezArea of Immunology, Department of Functional Biology, University of Oviedo, Oviedo, Spain. anasua@uniovi.es.ORCID http://orcid.org/0000-0002-4452-7539
Adriana S DussoBone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Instituto de Salud Carlos III · ESUniversidad de Oviedo · ESHospital Universitario Central de Asturias · ESConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is central to chronic kidney disease (CKD) pathogenesis and vascular outcomes, but the exact players remain unidentified. Since low density granulocytes (LDGs) are emerging mediators in inflammatory conditions, we aimed to evaluate whether LDGs may be altered in CKD and related to clinical outcomes as biomarkers. To his end, LDGs subsets were measured in peripheral blood by flow cytometry and confocal microscopy in 33 CKD patients undergoing peritoneal dialysis and 15 healthy controls (HC). Analyses were replicated in an additional cohort. DEF3 (marker of early granulopoiesis) gene expression on PBMCs was quantified by qPCR. Total CD15

Indexed as

AdultAgedBiomarkersFemaleGranulocytesHumansInflammationLeukocytes, MononuclearMaleMiddle AgedMonocytesNeutrophilsRenal Insufficiency, ChronicVascular CalcificationYoung AdultBiomarkers

Identifiers

PMID31519925
PMCPMC6744494
OpenAlexW2972522614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.